What is 10x Genomics, Inc.'s change in AR?

10x Genomics, Inc. (TXG) reported change in AR of -$7.98M in Q1 2026.

How has 10x Genomics, Inc.'s change in AR changed year-over-year?

10x Genomics, Inc.'s change in AR increased by 77.4% year-over-year, from -$35.33M to -$7.98M.

What is the long-term trend for 10x Genomics, Inc.'s change in AR?

Over 2 years (2021 to 2025), 10x Genomics, Inc.'s change in AR has grown at a 14.4% compound annual growth rate (CAGR), from $34.04M to -$44.55M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

10x Genomics, Inc. TXG Change in AR

Change in AR at other companies

IlluminaILMN

-$118M-157%

Twist Bioscience CorporationTWST

$14.24M+32.8%

RevvityRVTY

-$61.55M-239%

Tempus AI, Inc.TEM

-$1.99M-104%

Agilent TechnologiesA

$18M-40.0%

RepligenRGEN

-$3.19M-132%

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s change in AR?: 10x Genomics, Inc. (TXG) reported change in AR of -$7.98M in Q1 2026.
How has 10x Genomics, Inc.'s change in AR changed year-over-year?: 10x Genomics, Inc.'s change in AR increased by 77.4% year-over-year, from -$35.33M to -$7.98M.
What is the long-term trend for 10x Genomics, Inc.'s change in AR?: Over 2 years (2021 to 2025), 10x Genomics, Inc.'s change in AR has grown at a 14.4% compound annual growth rate (CAGR), from $34.04M to -$44.55M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.